[Present-day principles of cytostatic therapy of acute leukemia].
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017053:Infection Control; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007938:Leukemia / Q000188:drug therapy; D015122:Mercaptopurine / Q000008:administration & dosage; D008722:Methods; D008727:Methotrexate / Q000008:administration & dosage; D008938:Mitosis / Q000187:drug effects; D011239:Prednisolone / Q000008:administration & dosage; D012075:Remission, Spontaneous; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014750:Vincristine; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate
Printsipy sovremennoĭ tsitostaticheskoĭ terapii ostrogo leĭkotsitoza